Form 4: Genpact Director James Madden Awarded 7,582 Restricted Share Units
Insider Transaction Report
Genpact LTD Director James C. Madden was granted 7,582 unvested restricted share units, increasing his beneficial ownership to 63,068 common shares.
Summary
- Genpact LTD Director James C. Madden acquired 7,582 common shares on May 22, 2025, through an award of unvested restricted share units (RSUs).
- The RSUs were granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
- Each RSU entitles the holder to receive one common share at a future date.
- Subject to continued service, these RSUs will fully vest on December 31, 2025.
- The RSUs will be settled in common shares on December 31, 2026.
- Following this transaction, Mr. Madden beneficially owns a total of 63,068 common shares of Genpact LTD.
Sentiment
Score: 7
Explanation: The grant of restricted share units to a director is a positive sign of aligning management interests with shareholder value, reflecting standard compensation practices. It does not indicate any negative operational or financial issues.
Positives
- The grant of restricted share units aligns the director's long-term interests with those of the shareholders, incentivizing performance and retention.
- The transaction reflects a standard practice of equity compensation for board members, indicating stable corporate governance practices.
Risks
- The value of the granted RSUs is subject to the future market price of Genpact common shares, posing a market risk to the recipient.
- The RSUs are unvested and subject to the reporting person's continued service, meaning forfeiture could occur if service conditions are not met.
Future Outlook
The future outlook for these specific securities involves their vesting on December 31, 2025, contingent on continued service, and subsequent settlement into common shares on December 31, 2026.
Industry Context
The granting of restricted share units to directors is a common and widely accepted practice across various industries, including the business process management and IT services sector where Genpact operates. This form of compensation is used to attract, retain, and incentivize key personnel by aligning their financial interests with the long-term performance of the company.
Comparison to Industry Standards
- The use of Restricted Share Units (RSUs) as a component of director compensation is a standard practice observed in publicly traded companies globally, including peers in the IT services and consulting industry such as Accenture, Cognizant, and Wipro.
- The vesting schedule, typically tied to continued service over several years, is also consistent with industry benchmarks designed to promote long-term commitment and performance.
- The grant price of $0 for RSUs is typical, as RSUs represent a promise to deliver shares in the future, rather than an immediate purchase.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Utilization | The grant was made under the Genpact Limited 2017 Omnibus Incentive Compensation Plan, indicating the company's established framework for equity-based compensation. | 05/22/2025 | Reinforces the company's commitment to using equity incentives to align director interests with long-term shareholder value. |
Related Party Transactions
- The transaction involves the grant of equity compensation to James C. Madden, a director of Genpact LTD, which is considered a related party transaction.
Stakeholder Impact
- Shareholders: The grant aligns the director's interests with shareholder value, potentially leading to better long-term performance.
- Employees: While not directly impacting all employees, it sets a precedent for executive compensation practices within the company.
Next Steps
- Continued service of James C. Madden through December 31, 2025, for the RSUs to fully vest.
- Settlement of the vested RSUs into common shares on December 31, 2026.
Key Dates
| Date | Description |
|---|---|
| 05/22/2025 | Date of transaction (acquisition of RSUs). |
| 05/27/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
| 12/31/2025 | Date when the restricted share units will fully vest, subject to continued service. |
| 12/31/2026 | Date when the vested restricted share units will be settled in common shares. |
Keywords
Genpact, G, James Madden, Form 4, SEC filing, insider transaction, restricted stock units, RSU, equity compensation, director, beneficial ownership, corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.